Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.225EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.225ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.225ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.225EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.225EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.225ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MD.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MD.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MD.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LP.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LP.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LP.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.100 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used